Omar Boraie is an Egyptian immigrant who moved to New Brunswick in 1975, in pursuit of a Doctorate degree in Chemistry, before developing interest in real estate business. He founded Boraie Development LLC in 1976, with a dream to contribute in rebuilding New Brunswick in the same way he witnessed in Europe, on his way from Egypt as a Chemistry scholar. Omar Boraie supports many causes such as the recently established Rutgers University’s ’18 Chair Challenge’ campaign, as reported by Newswise.
The 18 Chair Challenge
This is a challenge through which Rutgers University aims to raise funds for 18 endowed chairs. An endowed chair is among the highest honors that can be achieved by a University faculty member. To establish one chair, the University requires a $3 million endowment, which covers the chair holder’s salary plus an annual research allowance.
This challenge is part of the University’s initiative to improve faculty and Research. Thus, whoever supports the cause contributes to broadening and enriching the many ways that Rutgers University serves not only New Jersey, but the world at large.
Omar Boraie Chair
Genomic Science is an emerging weapon in the fight against cancer. Genomic Science and Precision Medicine are transforming the ways of diagnosing and treating cancer. Rutgers Cancer Institute of New Jersey has established a chair to recognize accomplishments in the field.
The Omar Boraie Chair in Genomic Science is among the new endowment chairs established by Rutgers University’s “18 Chair Challenge” campaign. The chair is named after Omar Boraie, who apart from being a real estate developer, with a background in chemistry, has a long-established interest in cancer research.
The Boraie family has pledged $1.5 million in support of the initiative. This will match the $1.5 million from an anonymous donor, translating to a $3 million endowment. Boraie was optimistic that his family’s pledge will inspire others to support the cause, the same way the anonymous donor encouraged people to donate.
Rutgers Cancer Institute is among the first facilities in the United States and the only one in New Jersey to apply precision medicine, in form of genomic sequencing, for patient care. Boraie applauded the institution’s efforts to fight all types of cancers. He expressed his hope that the pledge will influence more support so that the life-changing initiative can satisfy and surpass its goal.